Showing results (271-280 of 376) with videos related to
Sort By:
Pageof 38
Cancers|December 19, 2019
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with GliomaPegah Mir Seyed Nazari, Christine Marosi, Florian Moik, et al.Blood|January 29, 2021
Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosisGeorg Obermayer, Taras Afonyushkin, Laura Göderle, et al.Transfusion|July 28, 2007
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cellsKatharina Schallmoser, Christina Bartmann, Eva Rohde, et al.Thrombosis and Haemostasis|February 21, 2022
Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid TumorsRamón Lecumberri, Pedro Ruiz-Artacho, Inna Tzoran, et al.Thrombosis Research|October 7, 2015
Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patientsDaniela Bianconi, Alexandra Schuler, Clemens Pausz, et al.Open Forum Infectious Diseases|December 15, 2025
Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter StudyStefan Hatzl, Christina Geiger, Lisa Kriegl, et al.Journal of Thrombosis and Haemostasis : JTH|June 5, 2025
Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopeniaTheresa Schramm, Jan Zlamal, Jasmin Rast, et al.ESMO Open|May 20, 2020
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with gliomaPegah Mir Seyed Nazari, Anna S Berghoff, Matthias Preusser, et al.Scientific Reports|August 29, 2025
Podoplanin expression is associated with local inflammation and survival in gliomaPegah Mir Seyed Nazari, Maximilian J Mair, Julia Riedl, et al.Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.Pageof 38